$8B Bayer cancer settlement offer may delay August trial

Bayer is offering to pay up to $8 billion to settle thousands of lawsuits claiming its weedkiller causes cancer, according to Bloomberg.

The Germany-based pharmaceutical company is facing more than 18,000 lawsuits linked to its Roundup herbicide, acquired in 2018 when it bought chemical giant Monsanto.

While Bayer has proposed $6 billion to $8 billion to resolve the lawsuits, plaintiffs' lawyers want more than $10 billion, according to the report. 

Negotiations have advanced to the point that lawyers for the plaintiffs and Bayer have asked two judges in St. Louis to postpone a trial that is set to begin this month. 

Read the full report here.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars